Steven Cohen 908 Devices Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.55 - $9.92 $8,515 - $12,896	-1,300 Reduced 6.44%	18,900 $142,000
Q4 2023 Feb 14, 2024	BUY	$4.96 - $12.41 $100,192 - $250,682	20,200 New	20,200 $226,000
Q2 2023 Aug 14, 2023	BUY	$5.78 - $10.02 $885,611 - $1.54 Million	153,220 New	153,220 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$36.7 - $55.11 $557,840 - $837,672	-15,200 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.94 - $75.0 $650,702 - $1.22 Million	-16,292 Reduced 51.73%	15,200 $737,000
Q4 2020 Feb 16, 2021	BUY	$49.0 - $67.92 $1.54 Million - $2.14 Million	31,492 New	31,492 $1.79 Million

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $82.5M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.